211 related articles for article (PubMed ID: 17483928)
1. [Chemoprevention of prostate cancer. Current status].
Schmitz-Dräger BJ; Lümmen G; Schäfer RM
Urologe A; 2007 Jun; 46(6):611-5. PubMed ID: 17483928
[TBL] [Abstract][Full Text] [Related]
2. [Chemoprevention of prostate cancer - a plea].
Schmitz-Dräger BJ; Bismarck E; Schöffski O; Fischer C
Aktuelle Urol; 2012 May; 43(3):157-61. PubMed ID: 22639024
[TBL] [Abstract][Full Text] [Related]
3. Risk adapted chemoprevention for prostate cancer: an option?
Schmitz-Dräger BJ; Schöffski O; Marberger M; Sahin S; Schmid HP
Recent Results Cancer Res; 2014; 202():79-91. PubMed ID: 24531781
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer prevention trial yields positive results, but with a few cautions.
Reynolds T
J Natl Cancer Inst; 2003 Jul; 95(14):1030-1. PubMed ID: 12865442
[No Abstract] [Full Text] [Related]
5. Role of 5α-reductase inhibitors in prostate cancer prevention and treatment.
Azzouni F; Mohler J
Urology; 2012 Jun; 79(6):1197-205. PubMed ID: 22446342
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of prostate cancer.
Vemana G; Hamilton RJ; Andriole GL; Freedland SJ
Annu Rev Med; 2014; 65():111-23. PubMed ID: 24188663
[TBL] [Abstract][Full Text] [Related]
7. Androgen antagonists: Potential role in prostate cancer prevention.
Trump DL; Waldstreicher JA; Kolvenbag G; Wissel PS; Neubauer BL
Urology; 2001 Apr; 57(4 Suppl 1):64-7. PubMed ID: 11295597
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer chemoprevention with 5α-reductase inhibitors.
Nepple KG; Andriole GL
Urol Oncol; 2012 Sep; 30(5):553-4. PubMed ID: 23193568
[No Abstract] [Full Text] [Related]
9. [The Prostate Cancer Prevention Trial (PCPT). Relevance for clinical practice].
Schmitz-Dräger BJ; Fischer C; Bismarck E; Dörsam HJ; Lümmen G
Urologe A; 2007 Oct; 46(10):1364, 1366-8, 1370. PubMed ID: 17874228
[TBL] [Abstract][Full Text] [Related]
10. The future of prostate cancer prevention.
Brawley OW; Barnes S; Parnes H
Ann N Y Acad Sci; 2001 Dec; 952():145-52. PubMed ID: 11795434
[TBL] [Abstract][Full Text] [Related]
11. [Chemoprevention of prostate cancer].
Djavan B; Thompson I; Michel MS; Waldert M; Seitz C
Urologe A; 2004 May; 43(5):557-61. PubMed ID: 15042290
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological approaches to reducing the risk of prostate cancer.
Rittmaster RS; Fleshner NE; Thompson IM
Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
[TBL] [Abstract][Full Text] [Related]
13. Role of 5a-reductase inhibitors and selective estrogen receptor modulators as potential chemopreventive agents for prostate cancer.
Price N; Sartor O; Hutson T; Mariani S
Clin Prostate Cancer; 2005 Mar; 3(4):211-4. PubMed ID: 15882476
[No Abstract] [Full Text] [Related]
14. Chemoprevention of prostate cancer.
Brawley OW; Thompson IM
Urology; 1994 May; 43(5):594-9. PubMed ID: 8165761
[TBL] [Abstract][Full Text] [Related]
15. Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development.
Lieberman R
Urology; 2001 Aug; 58(2 Suppl 1):83-90. PubMed ID: 11502457
[TBL] [Abstract][Full Text] [Related]
16. Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk.
Steiner MS; Raghow S
World J Urol; 2003 May; 21(1):31-6. PubMed ID: 12756492
[TBL] [Abstract][Full Text] [Related]
17. A review of phase III clinical trials of prostate cancer chemoprevention.
Thorpe JF; Jain S; Marczylo TH; Gescher AJ; Steward WP; Mellon JK
Ann R Coll Surg Engl; 2007 Apr; 89(3):207-11. PubMed ID: 17394699
[TBL] [Abstract][Full Text] [Related]
18. Selective estrogen receptor modulators for the chemoprevention of prostate cancer.
Steiner MS; Raghow S; Neubauer BL
Urology; 2001 Apr; 57(4 Suppl 1):68-72. PubMed ID: 11295598
[TBL] [Abstract][Full Text] [Related]
19. What's wrong with chemoprevention of prostate cancer?
Justman S
Am J Bioeth; 2011 Dec; 11(12):21-5. PubMed ID: 22146025
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of prostate cancer with finasteride.
Canby-Hagino ED; Brand TC; Hernandez J; Thompson IM
Expert Opin Pharmacother; 2006 May; 7(7):899-905. PubMed ID: 16634712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]